These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20859697)

  • 21. Semiautomated radiosynthesis and biological evaluation of [18F]FEAU: a novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression.
    Chin FT; Namavari M; Levi J; Subbarayan M; Ray P; Chen X; Gambhir SS
    Mol Imaging Biol; 2008; 10(2):82-91. PubMed ID: 18157580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [
    Vignal N; Cisternino S; Rizzo-Padoin N; San C; Hontonnou F; Gelé T; Declèves X; Sarda-Mantel L; Hosten B
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29875332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography.
    Iommelli F; De Rosa V; Gargiulo S; Panico M; Monti M; Greco A; Gramanzini M; Ortosecco G; Fonti R; Brunetti A; Del Vecchio S
    Clin Cancer Res; 2014 Sep; 20(18):4806-15. PubMed ID: 25052479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines.
    Engelman JA; Jänne PA; Mermel C; Pearlberg J; Mukohara T; Fleet C; Cichowski K; Johnson BE; Cantley LC
    Proc Natl Acad Sci U S A; 2005 Mar; 102(10):3788-93. PubMed ID: 15731348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations.
    Mukohara T; Engelman JA; Hanna NH; Yeap BY; Kobayashi S; Lindeman N; Halmos B; Pearlberg J; Tsuchihashi Z; Cantley LC; Tenen DG; Johnson BE; Jänne PA
    J Natl Cancer Inst; 2005 Aug; 97(16):1185-94. PubMed ID: 16106023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folate-PEG-NOTA-Al
    Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
    Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Evaluation of
    Song Y; Xiao Z; Wang K; Wang X; Zhang C; Fang F; Sun X; Shen B
    Sci Rep; 2017 Jun; 7(1):3121. PubMed ID: 28600491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative analysis of [11C]-erlotinib PET demonstrates specific binding for activating mutations of the EGFR kinase domain.
    Petrulli JR; Sullivan JM; Zheng MQ; Bennett DC; Charest J; Huang Y; Morris ED; Contessa JN
    Neoplasia; 2013 Dec; 15(12):1347-53. PubMed ID: 24403856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of panitumumab alone or with chemotherapy in non-small cell lung carcinoma cell lines expressing mutant epidermal growth factor receptor.
    Freeman DJ; Bush T; Ogbagabriel S; Belmontes B; Juan T; Plewa C; Van G; Johnson C; Radinsky R
    Mol Cancer Ther; 2009 Jun; 8(6):1536-46. PubMed ID: 19509246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a Fluorinated Analogue of Erlotinib for PET Imaging of EGFR Mutation-Positive NSCLC.
    Shamni O; Grievink H; Itamar B; Mishani E; Abourbeh G
    Mol Imaging Biol; 2019 Aug; 21(4):696-704. PubMed ID: 30377939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive efficacy of (11)C-PD153035 PET imaging for EGFR-tyrosine kinase inhibitor sensitivity in non-small cell lung cancer patients.
    Dai D; Li XF; Wang J; Liu JJ; Zhu YJ; Zhang Y; Wang Q; Xu WG
    Int J Cancer; 2016 Feb; 138(4):1003-12. PubMed ID: 26334931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [(11)C]erlotinib PET.
    Abourbeh G; Itamar B; Salnikov O; Beltsov S; Mishani E
    EJNMMI Res; 2015; 5():4. PubMed ID: 25853010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management.
    Sun X; Xiao Z; Chen G; Han Z; Liu Y; Zhang C; Sun Y; Song Y; Wang K; Fang F; Wang X; Lin Y; Xu L; Shao L; Li J; Cheng Z; Gambhir SS; Shen B
    Sci Transl Med; 2018 Mar; 10(431):. PubMed ID: 29515002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a new epidermal growth factor receptor positron emission tomography imaging agent based on the 3-cyanoquinoline core: synthesis and biological evaluation.
    Pisaneschi F; Nguyen QD; Shamsaei E; Glaser M; Robins E; Kaliszczak M; Smith G; Spivey AC; Aboagye EO
    Bioorg Med Chem; 2010 Sep; 18(18):6634-45. PubMed ID: 20797871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer.
    Zannetti A; Iommelli F; Speranza A; Salvatore M; Del Vecchio S
    J Nucl Med; 2012 Mar; 53(3):443-50. PubMed ID: 22331221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring of gefitinib sensitivity with radioiodinated PHY based on EGFR expression.
    Yoshimoto M; Hirata M; Kanai Y; Naka S; Nishii R; Kagawa S; Kawai K; Ohmomo Y
    Biol Pharm Bull; 2014; 37(3):355-60. PubMed ID: 24583857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PET.
    Pantaleo MA; Mishani E; Nanni C; Landuzzi L; Boschi S; Nicoletti G; Dissoki S; Paterini P; Piccaluga PP; Lodi F; Lollini PL; Fanti S; Biasco G
    Mol Imaging Biol; 2010 Dec; 12(6):616-25. PubMed ID: 20379787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and preliminary biological evaluation of O-2((2-[(18)F]fluoroethyl)methylamino)ethyltyrosine ([(18)F]FEMAET) as a potential cationic amino acid PET tracer for tumor imaging.
    Chiotellis A; Müller A; Weyermann K; Leutwiler DS; Schibli R; Ametamey SM; Krämer SD; Mu L
    Amino Acids; 2014 Aug; 46(8):1947-59. PubMed ID: 24802247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.